TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Apr 19, 2015 15:00 JST
L.R. Capital Prioritizes Investment Focuses into China
HONG KONG, Apr 19, 2015 - (ACN Newswire) - L.R. Capital, a leading global investment and alternative asset manager with branch offices in North America, Singapore, Hong Kong and mainland China, today announced it decided to priorities the investment focuses into the Greater China.
On March 23, L.R. Capital announced its cornerstone investment commitment in GF Securities H-Share IPO for US$ 250 million. GF Securities starts roadshow for its initial public offering in Hong Kong to raise up to US$3.6 billion, the largest listing in Asia so far this year.
With the attractive discount and valuation, the deal has generated strong interest from institutional investors. Among the cornerstone investors, Taiwan-based Fubon Financial has bought US$300 million, while L.R. Capital, the second largest cornerstone investor, has taken US$250 million of the shares.
According to news sources, this cornerstone investment in GF Securities indicates that L.R. Capital Group has decided to strengthen the scale of its investment in the Greater China and will be working harder to provide its current investment team with strategic coordination and development opportunities in China.
L.R. Capital's Global Advisory Committee consists of a few industry leaders and representatives, including Soul Htite, Co-founder of Lending Club and SinoLending, and Marcellus Wong, the former Head of taxation at PricewaterhouseCoopers Asia. L.R. Capital acts as a linkage for resources and capital by connecting China and the international markets, with focus in a wide range of sectors, mainly financial services, new energies, and technologies, in both developed and developing economies.
Sectors: Daily Finance
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Press Release
Honda to Begin Sales of All-new Prelude
Sep 04, 2025 13:20 JST
Signing of Agreement with Yamaguchi Prefecture and Iwakuni City to Construct Module Pack Plant of Automotive Cylindrical Lithium-Ion Batteries
Sep 04, 2025 11:54 JST
NEC to begin proof of concept for early earthquake detection and analysis in Colombia
Sep 04, 2025 11:15 JST
Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025
Sep 04, 2025 10:56 JST
Honda Premieres a New Color Option for Four Large-size Outboard Motors at HISWA In-Water Boat Show 2025 in the Netherlands
Sep 03, 2025 23:50 JST
Toyota Joins TOKYO H2 Project Aiming to Make Tokyo a Global Leader in Hydrogen
Sep 03, 2025 22:39 JST
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event
Sep 03, 2025 12:30 JST
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status
Sep 03, 2025 11:32 JST
Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025
Sep 03, 2025 11:00 JST
Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure
Sep 03, 2025 10:58 JST
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT
Sep 02, 2025 12:50 JST
Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework "SAFe(R)"
Sep 02, 2025 11:50 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Sep 01, 2025 22:28 JST
DENSO Signs Agreement to Transfer Part of Its Ceramic Product Business
Sep 01, 2025 20:52 JST
Honda to Provide Official Vehicles for World Athletics Championships Tokyo 25 as Official Global Partner
Sep 01, 2025 13:50 JST
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Sep 01, 2025 13:44 JST
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) - Applications for Research Projects Open on September 1
Sep 01, 2025 11:00 JST
ABVC BioPharma Receives $450,000 in Licensing Payments from OncoX BioPharma in Q3 2025
Aug 29, 2025 20:39 JST
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building
Aug 29, 2025 18:54 JST
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma
Aug 29, 2025 18:17 JST
More Latest Release >>